Standard Half-Life Factor VIII
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Standard Half-Life Factor VIII, covering 2025-09-18 to 2025-09-18. Get the full timeline:
Most recent: Clinical Trial Update: Pharmacokinetic Assessment of Standard Half-Life (SHL) FVIII, Extended Half-Life (EHL) FVIII, and Efanesoctocog Alfa (BIVV001) in Severe Hemophilia A [Phase 1]